CD49e is the integrin alpha 5 chain. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain.
| Inventor | Institute |
|---|---|
| Martin Humphries | University of Manchester |
| SKU: | 152487 |
|---|---|
| Product description: | CD49e is the integrin alpha 5 chain. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. Alpha chain 5 undergoes post translational cleavage in the extracellular domain to yield disulfide linked light and heavy chains that join with beta 1 to form a fibronectin receptor that is known variously: in lymphocytes as very late (activation) antigen 5 (VLA5); in platelets as glycoprotein IcIIa; and in fibroblasts as extracellular matrix receptor 6 (ECM… |
| Alternate name: | Integrin Subunit Alpha 5; Fibronectin Receptor Subunit Alpha; CD49 Antigen-Like Family Member E; Integrin Alpha-F; VLA-5; FNRA; Very Late Activation Protein 5; Alpha Subunit; Fibronectin Receptor; Alpha Polypeptide; Fibronectin Receptor; Alpha Subunit; Fibronectin Receptor; Alpha Polypeptide; Integrin Alpha; CD49e Antigen; CD49e; VLA5A |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a kappa |
| Immunogen: | Whole cells corresponding to human Integrin alpha5. |
| Myeloma used: | P3X63Ag8.653 |
| Cat. #: | 152487 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Apoptosis and autophagy;Cell biology;Cell signaling and signal transduction;Immunology |
| Application: | IF ; Fn ; WB |
| Target: | Integrin alpha5 (CD49e) |
| Reactivity: | Human |
| Clone: | SNAKA51 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | CD49e is the integrin alpha 5 chain. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. Alpha chain 5 undergoes post translational cleavage in the extracellular domain to yield disulfide linked light and heavy chains that join with beta 1 to form a fibronectin receptor that is known variously: in lymphocytes as very late (activation) antigen 5 (VLA5); in platelets as glycoprotein IcIIa; and in fibroblasts as extracellular matrix receptor 6 (ECM… |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Valdembri et al. 2009. PLoS Biol. 7(1):e25. PMID: 19175293. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. Clark et al. 2005. J Cell Sci. 118(Pt 2):291-300. PMID: 15615773. A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. |
|---|
Immunofluorescence on endothelial cells transfected with mNrp1-mRFP and Rab5-GFP and then incubated with anti-CD49e [SNAKA51]. mNrp1-mRFP and active a5b1 colocalize into Rab5-GFP-positive early endosomes as shown in merging (arrowheads). Lower panels are magnifications of the boxed areas shown in the upper panels. Taken from Valdembri et al. 2009. PLoS Biol. 7(1)
![Immunofluorescence on endothelial cells transfected with mNrp1-mRFP and Rab5-GFP and then incubated with anti-CD49e [SNAKA51]. mNrp1-mRFP and active a5b1 colocalize into Rab5-GFP-positive early endosomes as shown in merging (arrowheads). Lower panels are magnifications of the boxed areas shown in the upper panels. Taken from Valdembri et al. 2009. PLoS Biol. 7(1)](https://cancertools.org/wp-content/uploads/bd8af2d6-78ba-4733-a68f-7e14cbefc274.png)
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.